Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention
- 25 August 2002
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (4) , 669-675
- https://doi.org/10.1016/s0735-1097(02)02013-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Medical Therapy after Successful Percutaneous Coronary RevascularizationAnnals of Internal Medicine, 1999
- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStatistics in Medicine, 1998
- Estimating Causal Effects from Large Data Sets Using Propensity ScoresAnnals of Internal Medicine, 1997
- Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trialThe Lancet, 1997
- A Comparison of Angioplasty with Medical Therapy in the Treatment of Single-Vessel Coronary Artery DiseaseNew England Journal of Medicine, 1992
- Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trialEuropean Heart Journal, 1985
- A Randomized Trial of Propranolol in Patients With Acute Myocardial InfarctionJAMA, 1982
- The β-Blocker Heart Attack TrialPublished by American Medical Association (AMA) ,1981
- EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981